Mental health consequences of COVID-19 suppression strategies in Victoria, Australia: a narrative review von Jiang, Jacqueline, Akhlaghi, Hamed, Haywood, Darren, Morrissey, Brendan, Parnis, Stephen

Volltext

Will subspecialisation benefit the practice of Australasian emergency medicine? No von Parnis, Stephen

Volltext

Epidemiology, clinical presentations and outcome of patients presenting to the emergency department after a COVID‐19 vaccination: An observational study von Akhlaghi, Hamed, Dinou, Vasiliki, Jones, Hanna, Vorias, Blake, Moloney, James, Tse, Justin, Parnis, Stephen, Karro, Jonathan, Walby, Andrew, Morrissey, Brendan

Volltext

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer von Davis, Ian D, Martin, Andrew J, Stockler, Martin R, Begbie, Stephen, Chi, Kim N, Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, M. Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, T. Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G, Yip, Sonia, Zhang, Alison Y, Zielinski, Robert R, Sweeney, Christopher J

Volltext

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, doubl... von Tomczak, Piotr, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Gross-Goupil, Marine, Burgents, Joseph E, Xu, Lei, Imai, Kentaro, Choueiri, Toni K, Venugopal, Balaji, Lin, Tzu-Ping, Symeonides, Stefan N., Sawrycki, Piotr, Haas, Naomi B., Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Hammers, Hans-Joerg, Menezes, Juliana de Janoski, Winquist, Eric W., Hamzaj, Alketa, Karaszewska, Boguslawa, Lipatov, Oleg N., McDermott, David, Kochuparambil, Samith T., Davis, Ian D., Peltola, Katriina, Sabbatini, Roberto, Shkolnik, Michail I., McCune, Steven, Yeung, Carrie, Laguerre, Brigitte, Fomin, Eugeniy A., Zakharia, Yousef, Yorio, Jeffrey T., Yanez Ruiz, Eduardo, Kimura, Go, Nishimura, Kazuo, Masumori, Naoya, Kato, Haruaki, Sala Gonzalez, Nuria, Chiu, Kun-Yuan, Atkins, Michael B., Heath, Elisabeth, Feyerabend, Susan, Numakura, Kazuyuki, Zukov, Ruslan, Maroto Rey, Pablo Jose, Chang, Chao-Hsiang, Vengalil, Salil, Waddell, Tom S., Hauke, Ralph, Jayram, Gautam, Estay, Angela, Rubiano, Juan Andres, Anai, Satoshi, Tsunemori, Hiroyuki, Sikora-Kupis, Bozena, Gunderson, Elizabeth, Koletsky, Alan, Chen, Kevin, Agrawal, Manish, Parnis, Francis, Barbosa, Fernando Maciel, Faucher, Genevieve, Iqbal, Nayyer, Hanna, Nawar, Ibanez, Carolina, Manneh, Ray, Holeckova, Petra, Ronkainen, Hanna, Abadie-Lacourtoisie, Sophie, Goebell, Peter J., Hoefner, Thomas, Schultze-Seemann, Wolfgang, Yokomizo, Akira, Matsukawa, Yoshihisa, Murakami, Yoji, Kim, Miso, Szczylik, Cezary, Humphreys, Alison C., Kumar, Birendra, Karam, Jose Antonio, Fleming, Mark, Zarba, Juan Jose, Leiva, Viviana E., Antonio Junior, Joao Neif, Rocha, Roberto Odebrecht, Muniz, David, Brust, Leandro, Graham, Jeffrey, Borchiellini, Delphine, McDermott, Ray, Miura, Yuji, Prow, Debra M., Hashemi-Sadraei, Neda, Kendall, Stephan D.

Volltext

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an interna... von Sweeney, Christopher J, Martin, Andrew J, Stockler, Martin R, Cheung, Leanna, Chi, Kim N, Chowdhury, Simon, Frydenberg, Mark, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, Martin Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G, Yip, Sonia, Zielinski, Robert R, Davis, Ian D, Abdi, Ehtesham, Bastick, Patricia, Begbie, Stephen, Blum, Robert, Briscoe, Karen, Brungs, Daniel, Bydder, Sean, Chittajallu, Bala Renuka, Cronk, Michelle, Cuff, Katharine, Davis, Ian D, Dowling, Anthony, Frydenberg, Mark, Horvath, Lisa, Hovey, Elizabeth, Joshua, Anthony, Karanth, Narayan, Kichenadasse, Ganessan, Krieger, Laurence, Marx, Gavin, Mathlum, Maitham, Nott, Louise, Otty, Zulfiquer, Parnis, Francis, Pook, David, Sandhu, Shahneen, Sewak, Sanjeev, Stevanovic, Amanda, Suder, Aneta, Tan, Hsiang, Torres, Javier, Troon, Simon, Underhill, Craig, Weickhardt, Andrew, Zielinski, Robert, Anan, Ghadeer, Booth, Chris, Campbell, Holly, Chi, Kim, Chin, Joseph, Chouinard, Edmond, Drachenberg, Darrel, Faghih, Amir, Finelli, Antonio, Hotte, Sebastien, North, Scott, Rassouli, Mohammad, Reaume, Neil, Rendon, Ricardo, Saad, Fred, Sadikov, Evgeny, Vigneault, Eric, Zalewski, Pawel, McCaffrey, John, McDermott, Ray, Morris, Patrick, O'Connor, Miriam, Donnellan, Paul, Edwards, Jim, Fong, Peter, Tan, Alvin, Chowdhury, Simon, Crabb, Simon, Khan, Omar, Khoo, Vincent, Macdonald, Graham, Payne, Heather, Robinson, Angus, Shamash, Jonathon, Staffurth, John, Thomas, Carys, Thomson, Alastair, Sweeney, Christopher J

Volltext

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled... von Fizazi, Karim, Prof Dr, Scher, Howard I, Prof, Molina, Arturo, MD, Logothetis, Christopher J, Prof, Chi, Kim N, MD, Jones, Robert J, PhD, Staffurth, John N, MD, North, Scott, MD, Vogelzang, Nicholas J, MD, Saad, Fred, Prof, Mainwaring, Paul, MD, Harland, Stephen, MD, Goodman, Oscar B, MD, Sternberg, Cora N, MD, Li, Jin Hui, PhD, Kheoh, Thian, PhD, Haqq, Christopher M, MD, de Bono, Johann S, Prof

Volltext

Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial von Kelley, RobinKate, Ryoo, Baek-Yeol, Merle, Philippe, Park, Joong-Won, Bolondi, Luigi, Chan, Stephen L., Lim, HoYeong, Baron, Ari D., Parnis, Francis, Knox, Jennifer, Cattan, Stéphane, Yau, Thomas, Lougheed, Julie C., Milwee, Steven, El-Khoueiry, Anthony B., Cheng, Ann-Lii, Meyer, Tim, Abou-Alfa, Ghassan K.

Volltext

Abiraterone and Increased Survival in Metastatic Prostate Cancer von de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I

Volltext

Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP von Stockler, Martin R, Martin, Andrew J, Davis, Ian D, Dhillon, Haryana M, Begbie, Stephen D, Chi, Kim N, Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin M, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy R, Pook, David W, Reaume, M Neil, Sandhu, Shahneen, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G, Winter, Diana G, Yip, Sonia, Zhang, Alison Y, Zielinski, Robert R, Sweeney, Christopher J

Volltext

Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy von Sweeney, Christopher J., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Reaume, M. Neil, Sandhu, Shahneen K., Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia, Zhang, Alison Y., Zielinski, Robert R., Davis, Ian D.

Volltext

A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non‐clear‐cell renal cell carcinoma von Conduit, Ciara, Davis, Ian D., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Harris, Carole A., Pook, David, Krieger, Laurence, Parnis, Francis, Underhill, Craig, Adams, Diana, Roncolato, Felicia, Joshua, Anthony, Ferguson, Tom, Prithviraj, Prashanth, Morris, Michelle, Harrison, Michelle, Begbie, Stephen, Hovey, Elizabeth, George, Mathew, Liow, Elizabeth C., Link, Emma K., McJannett, Margaret, Gedye, Craig

Volltext

Prostate‐specific membrane antigen positron emission tomography‐computed tomography use prior to systemic therapy in metastatic castration‐resistant prostate cancer von Kelly, Richard, Jensen, Andrew, Karunaratna, Nathasha, Wong, Shirley, Shapiro, Julia, Weickhardt, Andrew, Parente, Phillip, Azad, Arun A., Uccellini, Anthony, Torres, Javier, Parnis, Francis, Goh, Jeffrey, Kwan, Edmond M., Brown, Stephen, Steer, Christopher, Warren, Mark, Gibbs, Peter, Tran, Ben, Anton, Angelyn

Volltext

Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcino... von Conduit, Ciara, Kichenadasse, Ganessan, Harris, Carole A., Gurney, Howard, Ferguson, Tom, Parnis, Francis, Goh, Jeffrey C., Morris, Michelle Frances, Underhill, Craig, Pook, David William, Davis, Ian D., Roncolato, Felicia, Harrison, Michelle L., Begbie, Stephen, Joshua, Anthony M., Link, Emma, Hovey, Elizabeth J., Gedye, Craig

Volltext

Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort von Fernando, Michael, Anton, Angelyn, Weickhardt, Andrew, Azad, Arun A., Uccellini, Anthony, Brown, Stephen, Wong, Shirley, Parente, Phillip, Shapiro, Julia, Liow, Elizabeth, Torres, Javier, Goh, Jeffrey, Parnis, Francis, Steer, Christopher, Warren, Mark, Gibbs, Peter, Tran, Ben

Volltext

Ipilimumab + nivolumab in people with rare variant renal cell carcinoma refractory to nivolumab alone: Part 2 of UNISON (ANZUP 1602) nivolumab then ipilimumab + nivolumab in advanc... von Gedye, Craig, Pook, David William, Krieger, Laurence Eliot Miles, Harris, Carole A., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Underhill, Craig, Parnis, Francis, Joshua, Anthony M., Ferguson, Tom, Roncolato, Felicia, Harrison, Michelle L., Begbie, Stephen, Morris, Michelle Frances, Hovey, Elizabeth J., George, Mathew, Prithviraj, Prashanth, Link, Emma, Davis, Ian D.

Volltext

UNISON - nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma (ANZUP 1602): Part 1—Nivolumab monotherapy von Gedye, Craig, Pook, David William, Krieger, Laurence Eliot Miles, Harris, Carole A., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Underhill, Craig, Parnis, Francis, Joshua, Anthony M., Ferguson, Tom, Roncolato, Felicia, Harrison, Michelle L., Begbie, Stephen, Morris, Michelle Frances, Hovey, Elizabeth J., George, Mathew, Prithviraj, Prashanth, Liow, Elizabeth Chien Hern, Davis, Ian D.

Volltext

Medical student knowledge and critical appraisal of machine learning: a multicentre international cross‐sectional study von Blacketer, Charlotte, Parnis, Roger, Franke, Kyle, Wagner, Morganne, Wang, David, Tan, Yiran, Oakden‐Rayner, Luke, Gallagher, Steve, Perry, Seth W., Licinio, Julio, Symonds, Ian, Thomas, Josephine, Duggan, Paul, Bacchi, Stephen

Volltext

Professionalism and clinical short answer question marking with machine learning von Lam, Antoinette, Lam, Lydia, Blacketer, Charlotte, Parnis, Roger, Franke, Kyle, Wagner, Morganne, Wang, David, Tan, Yiran, Oakden‐Rayner, Lauren, Gallagher, Steve, Perry, Seth W., Licinio, Julio, Symonds, Ian, Thomas, Josephine, Duggan, Paul, Bacchi, Stephen

Volltext

UNISON: Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602) von Gedye, Craig, Pook, David William, Krieger, Laurence Eliot Miles, Harris, Carole A., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Underhill, Craig, Parnis, Francis, Joshua, Anthony M., Ferguson, Thomas, Roncolato, Felicia, Harrison, Michelle L., Morris, Michelle Frances, Begbie, Stephen, Hovey, Elizabeth J., George, Mathew, Prithviraj, Prashanth, Liow, Elizabeth Chien Hern, Davis, Ian D.

Volltext